deltatrials
Unknown PHASE4 INTERVENTIONAL 1-arm NCT04798391

Effectiveness of Intratympanic Dexamethasone With Ligmocaine for Alleviation of Tinnitus

Effectiveness of Dexamethasone With Lignocaine for Alleviation of Tinnitus

Sponsor: Combined Military Hospital, Pakistan

Conditions Tinnitus
Interventions Dexamethasone
Updated 4 times since 2021 Last updated: Mar 12, 2021 Started: Mar 1, 2021 Primary completion: Apr 30, 2021 Completion: May 31, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04798391, this PHASE4 trial focuses on Tinnitus and remains ongoing. Sponsored by Combined Military Hospital, Pakistan, it has been updated 4 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Apr 2021 – ~Apr 2023 · 24 months · monthly snapshotActive Not Recruiting~Apr 2023 – ~Jul 2024 · 15 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

4 versions recorded
  1. Sep 2024 — Present [monthly]

    Unknown PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE4

    Status: Unknown StatusUnknown

  3. Apr 2023 — Jul 2024 [monthly]

    Unknown Status PHASE4

    Status: Active Not RecruitingUnknown Status

  4. Apr 2021 — Apr 2023 [monthly]

    Active Not Recruiting PHASE4

    First recorded

Mar 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Combined Military Hospital, Pakistan
Data source: Combined Military Hospital, Pakistan

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations